Wednesday, June 8, 2022

June 8, 2022 Gyn Cancer Research News #SGOmtg & #ASCO22

This month we reviewed the research presented during the SGO and ASCO Annual Meetings. We had twenty-six participants and 1.2 million impressions. You may read our transcript here and analytics here

Resources may be found at the end of the post. 

T1: What #SGOMtg presentations did you personally find of most interest? Anything practice-changing? 


T2: Which #ASCO22 studies do you think might be of most interest to patients?


T3: What are some of the current "hot topics" in gynecologic cancer research? Are there things still up for debate that patients/survivors/advocates should be aware of?

  • For me ~ anything that involves #immunotherapy or #targetedtherapy is something I want to know more about in #cancer treatment 
  • There seems to finally be some great momentum around endometrial cancer and addressing disparities. That is exciting to see and long overdue
  • Maximizing #treatment/#maintenance in HRD test negative #OvarianCancer remains a critical unmet need! 
  •  Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? 

T4: What research on palliative care, exercise, nutrition, survivorship do you think will impact patients lives the most - or that survivors should ask their providers about?

  • Studies showing ethnic minorities, especially black women, are less likely to understand their prognosis, less likely to use hospice and more likely to end up in the ICU. We need better communication! 
  • Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. 
  • I saw a study on better genetic education for ovarian cancer patients, but I don't remember a lot of quality of life studies in general. It was nice to see emphasis on financial toxicity though. 
  • Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing.
  • COUNSELING! Diagnosis, treatment, aftercare, terminal care. It’s important for EVERYONE involved.
  • @fumikochino has done great work in the area of financial toxicity.
  • New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors ⁦@NewsMedical#gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA

T5: Which equity issues were presented at #SGOmtg and #ASCO22? Are we seeing progress?

T6: For our last topic, we'll let our participants ask any questions they have about recent gynecologic cancer research. Also, what do you want to see research resources focused on? Are there gaps in research you would like to see addressed?

  • I'd like women with gyn #leiomyosarcoma who are treated in a private practice to know that they can get a second opinion from a #sarcoma medical oncologist. Collaboration helps patients know all of their options for treatment.
  • T6 I heard about women having PARP resistance - like becoming platinum resistant. I wonder how many cycles of PARP does this start? 
  • https://www.lmsdr.org/ is partnering with @SARCtrials to help @JoannaPrzybyl with her research on ctDNA in #leiomyosarcoma. It would be great if ULMS could be better detected before surgery
  • We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon


We will not be chatting in July but we hope to see you on August 10, 2022 at 8pmET for our chat on Advocacy for Yourself and Others

Have a safe July! 

Dee and Christina

 

RESOURCES 

Search Twitter for #SGOmtg  #ASCO22  #gyncsm  #leiomyosarcoma

 

SGO meeting : 

@stigetta - https://ocrahope.org/2022/04/ovarian-cancer-highlights-society-of-gynecologic-oncology-meeting-2022/

ASCO Post https://ascopost.com/Meetings/?m=SGO+2022+Annual+Meeting+on+Women%E2%80%99s+Cancer

Cancer Network https://www.cancernetwork.com/conference/sgo

Cancer Therapy Advisor https://www.cancertherapyadvisor.com/home/news/conference-coverage/society-of-gynecologic-oncology-sgo/sgo-2022/


ASCO Meeting :

ASCO Abstracts https://conferences.asco.org/am/abstracts-posters

ASCO Post https://ascopost.com/Meetings/?m=2022+ASCO+Annual+Meeting


Thursday, June 2, 2022

Gyn Cancer News - #SGOmtg & #ASCO22 June 8, 2022


Stay up to date with the latest gynecologic cancer research by joining the #gyncsm community as we discuss recent news from the SGO Annual Meeting (#SGOmtg) and the ASCO Annual Meeting (#ASCO22) during our June 8, 2022 chat at 8pmET. 
 
We will discuss HOT topics in gyn cancer research presented at both meetings, presentations that oncologists and patients who attended found most interesting, which research (including palliative care and survivorship) may make the greatest impact on patient lives, and cancer equity topics and the methods to improve the inequities. 

Chat Questions:

T1: What #SGOMtg presentations did you personally find of most interest? Anything practice-changing? 


T2: Which #ASCO22 studies do you think might be of most interest to patients?


T3: What are some of the current "hot topics" in gynecologic cancer research? Are there things still up for debate that patients/survivors/advocates should be aware of?


T4: What research on palliative care, exercise, nutrition, survivorship do you think will impact patients lives the most - or that survivors should ask their providers about?


T5: Which equity issues were presented at #SGOmtg and #ASCO22? Are we seeing progress?


T6: For our last topic, we'll let our participants ask any questions they have about recent gynecologic cancer research. Also, what do you want to see research resources focused on? Are there gaps in research you would like to see addressed?


 
We hope you can join us on Wednesday, June 8, 2022 at 8pm ET for this important chat. 

Dee and Christine
#gyncsm co-founders